CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression.
Cai H, Zhang B, Ahrenfeldt J, Joseph JV, Riedel M, Gao Z, Thomsen SK, Christensen DS, Bak RO, Hager H, Vendelbo MH, Gao X, Birkbak N, Thomsen MK.
Cai H, et al. Among authors: ahrenfeldt j.
Nat Commun. 2024 Mar 7;15(1):2088. doi: 10.1038/s41467-024-46370-0.
Nat Commun. 2024.
PMID: 38453924
Free PMC article.